title: [Clinical significance of H. pylori genotyping].
abstract: Clinical implications of H. pylori genotyping are analysed. H. pylori usually occurs during exacerbation of duodenal ulcer (91.7%) and lymphocytic gastritis (93.5%). CagA strains of H. pylori most frequently develop resistance to metronidazole (50.5%), furazolidone (15.1%), amxicillin (13.2%), and tetracycline (11.3%).
authors.forename: G K
authors.initials: GK
authors.lastname: Mirodzhov
authors.forename: F Kh
authors.initials: FKh
authors.lastname: Mansurova
authors.forename: D M
authors.initials: DM
authors.lastname: Ishankulova
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000235:genetics*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000382:microbiology*; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D016480:Helicobacter pylori / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D007413:Intestinal Mucosa / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D004269:DNA, Bacterial